Strategies for the prevention of infection in the myelosuppressed or immunosuppressed cancer patient.
D000380:Agranulocytosis / Q000517:prevention & control; D001853:Bone Marrow / Q000503:physiopathology*; D003141:Communicable Diseases / Q000150:complications*; D003428:Cross Infection / Q000150:complications / Q000517:prevention & control*; D006801:Humans; D007165:Immunosuppression Therapy; D009369:Neoplasms / Q000150:complications* / Q000276:immunology